Attached files
| file | filename |
|---|---|
| EX-23.1 - EX-23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Viracta Therapeutics, Inc. | snss-ex231_6.htm |
| EX-32.1 - EX-32.1 - Viracta Therapeutics, Inc. | snss-ex321_9.htm |
| EX-31.2 - EX-31.2 - Viracta Therapeutics, Inc. | snss-ex312_8.htm |
| EX-31.1 - EX-31.1 - Viracta Therapeutics, Inc. | snss-ex311_7.htm |
| EX-10.45 - EX-10.45 - Viracta Therapeutics, Inc. | snss-ex1045_11.htm |
| EX-10.44 - EX-10.44 - Viracta Therapeutics, Inc. | snss-ex1044_10.htm |
| EX-10.43 - EX-10.43 - Viracta Therapeutics, Inc. | snss-ex1043_12.htm |
| EX-10.42 - EX-10.42 - Viracta Therapeutics, Inc. | snss-ex1042_13.htm |
| 10-K - 2017 10-K VERSION 2.0 - Viracta Therapeutics, Inc. | snss-10k_20171231.htm |
Exhibit 21.1
List of Subsidiaries
|
Subsidiary Legal Name |
State or other Jurisdiction of Incorporation |
|
Sunesis Pharmaceuticals (Bermuda) Ltd. |
Bermuda |
|
Sunesis Europe Limited Sunesis Pharmaceuticals International LP |
United Kingdom Bermuda |